Abionic Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
28
- Latest Deal Type
-
2ndary - Private
- Investors
-
6
Abionic General Information
Description
Developer of rapid point-of-care diagnostic systems designed to improve medical diagnosis through early detection and monitoring of sepsis in hospital settings. The company's systems combine the nanofluidic platform with single-cartridge immunoassays and the Pancreatic Stone Protein (PSP) biomarker to deliver lab-quality results from a small whole-blood sample within minutes, enabling emergency and critical-care teams to identify sepsis risk earlier and support timely clinical intervention.
Contact Information
Website
www.abionic.comCorporate Office
- Route de la Corniche 5
- Epalinges
- 1066 Lausanne
- Switzerland
Corporate Office
- Route de la Corniche 5
- Epalinges
- 1066 Lausanne
- Switzerland
Abionic Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 13. Later Stage VC | 01-Jan-2024 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 11. Later Stage VC (Series E) | 12-Apr-2022 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series C) | 28-Mar-2018 | Completed | Generating Revenue | |||
| 9. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 8. Early Stage VC (Series B) | 14-Oct-2014 | Completed | Generating Revenue | |||
| 7. Debt - General | 30-Oct-2013 | Completed | Startup | |||
| 6. Early Stage VC (Series A) | 12-Apr-2012 | $3.84M | $3.84M | Completed | Startup | |
| 5. Grant | 03-Nov-2010 | $124K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Abionic Comparisons
Industry
Financing
Details
Abionic Competitors (27)
One of Abionic’s 27 competitors is QuantuMDx, a Venture Capital-Backed company based in Newcastle Upon Tyne, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| QuantuMDx | Venture Capital-Backed | Newcastle Upon Tyne, United Kingdom | ||||
| Nuclein | Venture Capital-Backed | Austin, TX | ||||
| 1Drop | Formerly VC-backed | Neuchatel, Switzerland | ||||
| LamdaGen Corporation | Formerly VC-backed | Menlo Park, CA | ||||
| miDiagnostics | Venture Capital-Backed | Leuven, Belgium |
Abionic Patents
Abionic Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021475717-A1 | Method for the management of antibiotic administration | Pending | 25-Nov-2021 | ||
| CA-3233713-A1 | Method for the management of antibiotic administration | Pending | 25-Nov-2021 | ||
| EP-4437346-A1 | Method for the management of antibiotic administration | Pending | 25-Nov-2021 | ||
| US-20250020663-A1 | Method for the management of antibiotic administration | Pending | 25-Nov-2021 | ||
| WO-2023094862-A1 | Method for the management of antibiotic administration | Inactive | 25-Nov-2021 | G01N33/6893 |
Abionic Signals
Abionic Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Numan Wealth Partners | Family Office | Minority | ||
| EFI Lake Geneva Ventures | Venture Capital | Minority | ||
| Nest Sammelstiftung | Limited Partner | Minority | ||
| Verve Ventures | Venture Capital | Minority | ||
| Drexel Morgan | Corporation | Minority |
Abionic FAQs
-
When was Abionic founded?
Abionic was founded in 2010.
-
Where is Abionic headquartered?
Abionic is headquartered in Lausanne, Switzerland.
-
What is the size of Abionic?
Abionic has 28 total employees.
-
What industry is Abionic in?
Abionic’s primary industry is Diagnostic Equipment.
-
Is Abionic a private or public company?
Abionic is a Private company.
-
What is Abionic’s current revenue?
The current revenue for Abionic is .
-
How much funding has Abionic raised over time?
Abionic has raised $30.1M.
-
Who are Abionic’s investors?
Numan Wealth Partners, EFI Lake Geneva Ventures, Nest Sammelstiftung, Verve Ventures, and Drexel Morgan are 5 of 6 investors who have invested in Abionic.
-
Who are Abionic’s competitors?
QuantuMDx, Nuclein, 1Drop, LamdaGen Corporation, and miDiagnostics are some of the 27 competitors of Abionic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process